F star Therapeutics : Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Oct. 20, 2021 -- F-star Therapeutics, Ltd.  , a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies... | October 20, 2021

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Helen Shik ,Lindsey Trickett ,Linkedin ,Janssen Biotech Inc ,Twitter ,Therapeutics Ltd ,Janssen Pharmaceutical Companies Of Johnson ,Therapeutics Inc ,Shik Communications ,Globenewswire Inc ,Janssen Pharmaceutical Companies ,Chief Scientific Officer ,F Star Therapeutics ,Private Securities Litigation Reform Act ,Nc Stock Exchange ,News ,Information ,Press Release ,United ,Kingdom ,End ,021 ,Iopharmaceutical ,Company ,Edicated ,O ,Developing ,Text ,Eneration Fstx Us30315r1077 ,